Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03VNX
|
||||
Former ID |
DNAP001443
|
||||
Drug Name |
Pro-urokinase
|
||||
Synonyms |
Thrombolyse (TN)
|
||||
Indication | Thrombin deficiency [ICD9: 437.6, 444.9, 453, 671.5, 671.9; ICD10:I74, I80-I82, I82, O88, T79.0-T79.1] | Approved | [551871] | ||
Target and Pathway | |||||
Target(s) | Urokinase-type plasminogen activator | Target Info | Modulator | [543617] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
EGFR1 Signaling Pathway | |||||
Pathway Interaction Database | Beta1 integrin cell surface interactions | ||||
E2F transcription factor network | |||||
Beta3 integrin cell surface interactions | |||||
Osteopontin-mediated events | |||||
Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||||
amb2 Integrin signaling | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
Beta2 integrin cell surface interactions | |||||
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||||
Beta5 beta6 beta7 and beta8 integrin cell surface interactions | |||||
FGF signaling pathway | |||||
Reactome | Dissolution of Fibrin Clot | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.